Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. The company offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. Its principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. The company also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. Daewon Pharmaceutical Co., Ltd. was founded in 1958 and is headquartered in Seoul, South Korea.
daewon pharmaceutical co ltd
Phone: 82 2 2204 7000
Fax: 82 2 498 9108www.daewonpharm.com
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for 003220.|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact DAEWON PHARMACEUTICAL CO LTD, please visit www.daewonpharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.